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FIGURE 2. Mean changes in systemic and extracorporeal membrane oxy-
genationparameters duringphases I and II.HR,Heart rate;MAP,meanarterial
pressure; SpO2, arterial oxygen saturation; SvO2, venous oxygen saturation.
Brief Clinical Reportsin HbO2 concentrations could be explained by a compensa-
tory arterial dilation.
We demonstrate that multichannel optical topographic
analysis can provide information on regional cerebral
hemodynamics and oxygenation in patients supported by
ECMO. Simultaneous measurement of systemic and cere-
bral HbO2 and HHb concentrations can help elucidate
mechanisms related to the response of the brain during
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The Journal of Thoracic and CaIn this patient modest changes in ECMO flows appear to
present a significant hemodynamic challenge to cerebral
circulation. Further work is necessary to support application
of this novel brain-monitoring technology in cardiac
theaters and intensive care units, andwe nowhave a protocol
to further investigate regional brain oxygenation in these
patients.References
1. Nollert G, Shin’oka T, Jonas RA. Near infrared spectrophotometry of the brain in
cardiovascular surgery. Thorac Cardiovasc Surg. 1998;46:167-75.
2. Austin EH 3rd, Edmonds HL Jr, Auden SM, Seremet V, Niznik G, Sehic A, et al.
Benefit of neurophysiologic monitoring for pediatric cardiac surgery. J Thorac
Cardiovasc Surg. 1997;114:707-15.
3. Hirsch JC, Charpie JR, Ohye RG, Gurney JG. Near infrared spectroscopy (NIRS)
should not be standard of care for postoperative management. Semin Thorac
Cardiovasc Surg Pediatr Card Surg Annu. 2010;13:51-4.
4. Tortoriello TA, Stayer SA, Mott AR, McKenzie ED, Fraser CD, Andropoulos DB,
et al. A noninvasive estimation of mixed venous oxygen saturation using near-
infrared spectroscopy by cerebral oximetry in pediatric cardiac surgery patients.
Paediatr Anaesth. 2005;15:495-503.
5. Papademetriou MD, Tachtsidis I, Leung TS, Elliott MJ, Hoskote A,
Elwell CE. Cerebral and peripheral tissue oxygenation in children supported
on ECMO for cardio-respiratory failure. Adv Exp Med Biol. 2010;662:
447-53.Seven-year outcome of pulmonary valve autograft replacement of the
mitral valve in an infantTomohito Kanzaki, MD,a Masaaki Yamagishi, MD, PhD,a Masafumi Yashima, MD,a and
Hitoshi Yaku, MD, PhD,b Kyoto, JapanPulmonary autograft replacement of the mitral valve1 ap-
pears to be a useful alternative for children with irreparable
mitral valve disease. Long-term results, however, have yet
to be reported. We previously reported a case of mitral valve
replacement with a Gore-Tex–reinforced (W. L. Gore &
Associates, Inc, Flagstaff, Ariz) pulmonary autograft in
a child.2 In this report, we described the fate of the
pulmonary autograft 7 years after that operation.CLINICAL SUMMARY
A girl with a partial atrioventricular septal defect and
severe mitral regurgitation underwent pulmonary auto-
graft replacement of the mitral valve when 11 months
old. The pulmonary autograft was anastomosed to an ap-
propriately sized Gore-Tex expanded polytetrafluoroethy-
lene (ePTFE) graft.2 The ePTFE felt strip was looped
around and sewn onto the outer surface of the Gore-Tex
graft as a sewing cuff. The pulmonary autograft with
the ePTFE external cylinder was inserted into the mitral
annulus, and the ePTFE felt band was anastomosed to
the mitral annulus. The implanted valve did not protrude
into either the left ventricle or the left atrium. The oper-
ation was successful, and the patient was further treated
with medications including diuretics, digoxin, and an
angiotensin-converting enzyme inhibitor for treatment of
chronic heart failure. Six years after the operation, an
echocardiogram showed mild mitral regurgitation but no
significant mitral stenosis. A follow-up cardiac catheteri-
zation demonstrated growth of fibrous tissue causing therdiovascular Surgery c Volume 141, Number 5 e33
FIGURE 1. Changes of flow velocity across the pulmonary autograft in the mitral position. Despite body weight and body surface area (BSA) gains, the
velocity was relatively stable until 6 years after pulmonary autograft replacement of the mitral valve. The velocity was rapidly increased, however, 7 years
after the operation.
Brief Clinical Reportssubaortic stenosis, which was believed to be the cause of
her chronic heart failure. We initially planned a resection
of the subaortic fibrous tissue. While the patient was wait-
ing for her operation, however, another echocardiogram
demonstrated worsening mitral regurgitation, with the
peak blood flow velocity across the mitral valve rapidly
increasing from 2.6 m/s to 3.59 m/s (Figure 1). Also,
the ascending aorta–left ventricle pressure gradient in-
creased from 60 mm Hg to 90 mm Hg. The patient’s
left ventricular ejection fraction was 73%. We therefore
decided to perform a reoperation 7 years after her initial
pulmonary autograft replacement of the mitral valve. At
that time, her body weight had increased from 7 kg to
20 kg, and her body surface area was 0.78 m2. The mitral
annular diameter was 14 mm (52% of normal value)
according to echocardiography.
After establishment of cardiopulmonary bypass, the
pulmonary autograft was harvested by cutting the PTFE
felt suturing cuff wrapped around the pulmonary auto-
graft. Each of the cusps of the pulmonary autograft was
slightly thickened; however, no deformity or calcification
was detected. Mobility and coaptation of the cusps were
well maintained (Figure 2). Subaortic stenosis was
caused by overgrowth of the fibrous ring tissue. The
ePTFE outer cylinder of the pulmonary autograft was
not directly involved with the subaortic stenosis. The sub-
aortic fibrous ring was completely resected. Both aortic
and mitral annuli were enlarged by cutting the mitral–
aortic fibrous continuity. A 23-mm ATS valve (ATS
Medical, Inc, Minneapolis, Minn) was implanted ate34 The Journal of Thoracic and Cardiovascular Surgmitral position, and an 18-mm ATS valve was implanted
at the aortic position.
DISCUSSION
Because of the demands of patient growth and the
long-term durability concerns regarding prosthetic
valves, the mitral valve should be repaired as early as
possible once regurgitation has been detected in children.
When there is intractable mitral deformity, however, such
as dysplastic leaflets or a severe abnormality of the sub-
valvular apparatus, we have no choice but to replace the
mitral valve with prosthetic materials. There is no appro-
priate prosthetic valve for infants that has both growth
potential and lifelong durability. Sizing of the prosthetic
valve is also very limited, and anticoagulation therapy for
mechanical valves is a relatively difficult problem in
the pediatric population. Finally, biologic valves have
a tendency toward early degeneration and calcification
in pediatric patients.3
As an alternative procedure, replacement of themitral valve
with apulmonaryautograft is ausefuloption for intractablepe-
diatric mitral valve disease,1,2,4,5 especially in children with
narrow mitral annulus. During the procedure, reinforcement
of the pulmonary outer wall is necessary to retain a suitable
pulmonary valve configuration. If the pulmonary autograft
with a round annulus is implanted into an elliptical mitral
annulus without reinforcement of the pulmonary wall,
the pulmonary annulus may distort elliptically and the
pulmonary commissures may bend inward against the inner
pressure of the left ventricle, resulting in valve dysfunction.ery c May 2011
FIGURE 2. Left, Preimplantation views of the pulmonary autograft bearing the expanded polytetrafluoroethylene external cylinder. Right, Resected
pulmonary autograft 7 years after pulmonary autograft replacement of the mitral valve (op.). The pulmonary autograft showed no significant
constriction or deformation. Each of the cusps was a little thickened, but the mobility and coaptation were well preserved. LA, Left atrial; LV, left
ventricular.
Brief Clinical ReportsOn the other hand, the growth potential of the pulmonary
autograft is compromised by this prosthetic material
reinforcement. Although reoperation seems inevitable
because of relative mitral stenosis with an increase in body
weight, the pulmonary autograft in this case maintained
an ideal configuration and a satisfactory performance for
7 years without anticoagulation. Reinforcement with
a cylinder of ePTFE is an efficient procedure to maintain
pulmonary autograft configuration and function.
In conclusion, pulmonary autograft replacement of the
mitral valve is a useful alternative procedure for intractable
congenital mitral valve disease in young infants.The Journal of Thoracic and CaReferences
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